Remove 2024 Remove Intellectual Property Remove Licensing Remove Ownership
article thumbnail

Intellectual Property Rights in the Metaverse: Navigating the Virtual Frontier

IIPRD

Introduction Before hunting into the intricacies of Intellectual Property Rights (IPR) in the metaverse, it is essential to know what the metaverse entails. In the metaverse and physical world, the notion of Intellectual Property Rights (IPR) has a murky image.

article thumbnail

Federal Circuit Weighs in on Temporal Rigidity of the Baye-Dole Act’s Licensing Provisions

Intellectual Property Law Blog

United States , [1] the Federal Circuit rejected a strict temporal limitation on when the Government’s license rights in patents stemming from federally funded research is triggered under the Bayh-Dole Act. The funding agency obtains a license to “subject inventions,” which is defined as “any invention. . . February 9, 2024)

Licensing 130
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The USPTO and USCO Delivered a Report to Congress on IP Issues with NFTs – Maintains Existing IP Regime

Intellectual Property Law Blog

The United States Patent and Trademark Office (“USPTO”) and the United States Copyright Office (“USCO”) delivered a report to Congress entitled Non-Fungible Tokens and Intellectual Property on March 12, 2024 (“Report”). While the Report is comprehensive, it does not recommend any new action to address IP issues with NFTs.

Reporting 130
article thumbnail

Understanding the Beneficial Ownership Information Reporting Rule

LexBlog IP

Understanding the Beneficial Ownership Information Reporting Rule by Josh Slovin The New Beneficial Ownership Reporting Rule: A Step towards Greater Transparency in US Businesses Privately-owned companies in the United States have long enjoyed a great degree of privacy about their internal affairs, particularly as to the identities of their owners.

article thumbnail

Balancing Innovation: India’s Views for Pharmaceuticals in the Efta Trade Deal

IIPRD

i] Recently, the trend of increasing prevalence of TRIPS-Plus provisions within these trade agreements introduces stricter intellectual property (IP) regimes. xii] This clause gives the original researchers ownership of their clinical trial data for a predetermined amount of time, usually ranging for a period of six years.

article thumbnail

…And The Covaxin Patent Saga Continues: BBIL Changes the Patent Application Again

SpicyIP

In late June this year, I wrote ( here ) about how Bharat Biotech (BBIL) filed a patent application for Covaxin without listing the Indian Council of Medical Research (ICMR) as a co-patentee or inventor, despite the Health Ministry asserting that the intellectual property rights over Covaxin are “jointly owned” by ICMR and BBIL.

article thumbnail

Federal Circuit Weighs in on Temporal Rigidity of the Baye-Dole Act’s Licensing Provisions

LexBlog IP

United States , [1] the Federal Circuit rejected a strict temporal limitation on when the Government’s license rights in patents stemming from federally funded research is triggered under the Bayh-Dole Act. The funding agency obtains a license to “subject inventions,” which is defined as “any invention.